Personal Finance »
Is Mind Reading Inside Information?
03/08/2010 – 7:10 am PST | No Comment

Source: SEC New Release
SEC Charges Nationally Known Psychic in Multi-Million Dollar Securities Fraud
FOR IMMEDIATE RELEASE 2010-34
Washington, D.C., March 4, 2010 — The Securities and Exchange Commission today charged a self-proclaimed psychic …

Read the full story »
Investing & Markets

Make better decisions with investing tips, technical analysis, market commentary, and more

Personal Finance

Make more, save more, spend smarter, and keep more of what you earn

Business News

Stock market news & analysis

Home » Archive by Tags

Articles tagged with: ALTH

Allos Provides New Folotyn Data (NASDAQ:ALTH)
12/08/2009 – 7:45 am PST | No Comment
Allos Provides New Folotyn Data (NASDAQ:ALTH)

Allos Therapeutics Inc (NASDAQ:ALTH) has reported a new analysis of data from the pivotal PROPEL trial of FOLOTYN in patients who are suffering from relapsed and refractory peripheral T-cell lymphoma (PTCL).

Allos Therapeutics Offering (NASDAQ:ALTH)
10/08/2009 – 9:00 am PDT | No Comment
Allos Therapeutics Offering (NASDAQ:ALTH)

Allos Therapeutics has announced on Wednesday morning that they will be expanding the share offerings and will now sell around 14 million shares for $7.10 per share. On Monday, Allos Therapeutics has already announced that …

Folotyn drug gets FDA approval (Nasdaq:ALTH)
09/28/2009 – 10:10 am PDT | No Comment
Folotyn drug gets FDA approval (Nasdaq:ALTH)

Allos Therapeutics Inc (Nasdaq:ALTH) must be delighted with joy after getting a green signal by the FDA panel for their injectable drug Folotyn, which will be used for the treatment of peripheral T-cell lymphoma, a rare …